Studies on the most traded medicinal plants from the dolpa district of nepal by Gewali Mohan B
STUDIES ON THE MOST TRADED MEDICINAL PLANTS FROM THE 
DOLPA DISTRICT OF NEPAL 
Mohan B. Gewali 
Division of Visiting Professors 
Institute of Natural Medicine 
University of Toyama 
Abstract
The traditional uses, major chemical constituents and prominent biological activities of 
the most traded medicinal plants from Dolpa district of Nepal are described in this 
article.  
Cradled on the laps of the central Himalayan range, Nepal (147,181 Km
2
) is 
sandwiched between two Asian giants, India on the South and China on the North. 
Nepal is divided into 14 zones and 75 districts. The Karnali zone, which has a border 
with Tibet region of China, is made up of five districts. Dolpa district (7,889 km²) is one 
of them. 
Dolpa district’s topography starts from the subtropical region (1575 meter) and 
ends in the nival region (6883 meter) in the trans-Himalayan region. The district has a 
population of about 29545 with Hindu 60%, Buddhist 40% including 5.5% ancient 
Bonpo Religion. Major ethnic groups/castes belonging to both Hindu and Buddhist 
religions include Kshetri, Dangi, Rokaya, Shahi, Buda, Thakuri, Thakulla, Brahmins, 
Karki, Shrestha, Sherpa and other people of Tibetan origin. The languages spoken are 
Nepali, Dolpo and Kaike. Dolpo is a variant of the Tibetan language. Kaike is 
considered indigenous language of Tichurong valley. In the Dolpa district, the 
traditional Tibetan medical practices are common. The traditional Tibetan practitioners 
called the Amchis provide the health care service. The Amchis have profound 
knowledge about the medicinal herbs and the associated healing properties of the 
medicinal plants found in the Dolpa district. 
As far as the ethnomedicinal resources of the Dolpa district is concerned, there 
seems to be three key studies. They are Medicinal Plants of Dolpo: Amchi's Knowledge 
and Conservation (1), Ethnomedicine of Dolpa district, Nepal: the Plants, their 
Vernacular Names and Uses (2) and Ethnomedicine in Himalaya: a case study from 
Dolpa, Humla, Jumla and Mustang districts of Nepal (3). In Medicinal Plants of Dolpo: 
Amchi's Knowledge and Conservation, descriptions as regards to the Amchis’s 
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traditional medical and ethnoecological acumen, relationship between conservation, 
health care and the trade of medicinal plants as well as the traditional uses of 100 
medicinal plants in Shey Phoksundo National Park and its buffer zone are presented. 
The second study, Ethnomedicine of Dolpa district, Nepal: the Plants, their Vernacular 
Names and Uses, documents 58 medicinal plant species used by the local people of 
dunai, juphal, suu, sahartara and majphal villages of the Dolpa district. Furthermore, 
from dunai, juphal, raha, tripurakot and phoksundo villages of Dolpa district, 107 plants 
of the ethnomedicinal importance are reported in Ethnomedicine in Himalaya: a case 
study from Dolpa, Humla, Jumla and Mustang districts of Nepal. The Amchis of the 
Dolpa district are reported to use at least 375 plants in their traditional treatment to cure 
variety of the diseases (4). Based on the records available in the District Forest Office as 
well as field surveys during the period of 1992/1993 and 1997/1998, 20 plants were 
found to be the most traded from the Dolpa district (5). The names of these 20 plants are 
given in the following table. 
Trade name Scientific name 
1 Atis Delphinium himalayai Munz 
2 Bhutkesh Selinum wallichianum (DC.) Raizada & Saxena 
3 Bojho Acorus calamus L. 
4 Chau  Morchella esculenta (L.) Pers. ex Fr. 
5 Chirayita Swertia chirayita (Roxb. ex Fleming) Karsten 
6 Dhupi 
7 Dhupjadi Jurinea dolomiaea Boiss. 
8 Jatamansi Nardostachys grandiflora DC. 
9 Kakarsinghi Pistacia khinjuk Stocks 
10 Kurilo Asparagus sp. 
11 Kutki Neopicrorhiza scrophulariiflora (Pennell) D.Y. Hong 
12 Nirbisi 
13 Okhar Juglans regia L. 
14 Padamchal Rheum australe D. Don 
15 Kaladana 
16 Salla simta Pinus wallichiana A. B. Jacks. 
17 Satuwa  Paris polyphylla Sm. 
18 Satawari Asparagus racemosus Willd.  
19 Sugandhbal  Valeriana jatamansii Jones 
20 Titepati  Artemisia sp. 
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In this article, out of these 20 most traded plants, 15 plants were selected. The chemical 
constituents and biological activities present in these 15 plants were searched. The 
traditional uses of the plants are taken from recently published two ethnomedicinal 
studies of the Dolpa district (2) (3). If the traditional uses of certain plants are not 
obtained in these two studies, information as regards to the traditional use is sourced 
from National Register of Medicinal Plants (6). Most of the distribution and location of 
the plants are based on the information obtained from Annoted Checklist of the 
Flowering Plants of Nepal (7). The following is the description of the traditional uses, 
principal chemical constituents and major biological properties of the 15 most traded 
medicinal plants from the Dolpa district. 
Delphinium himalayai
Delphinium himalayai Munz. (Amchi term: Atik; Nepali language and trade name: Atis)
belongs to the family Ranunculaceae. It is distributed in Nepal at the elevation range of 
3000 to 4500 meter. 
Traditional use  
Its root has been used as an astringent. The root juice is useful in case of snakebite, 
cough, fever, liver problems and headache. 
Chemical constituents and biological properties 
Chemical and biological studies are lacking in this plant. 
Selinum wallichianum
Selinum wallichianum (DC.) Raizada & Saxena (Synonym: Selinum tenuifolium Wall. 
ex C. B. Clarke) (Amchi term: Tanak; Nepali language and trade name: Bhutkesh)
belongs to the family Umbelliferae. It is distributed in the Himalayan region (Kashmir 
to Bhutan), Tibet and China at the elevation range of 2600 to 4200 meter. 
Traditional use  
Root decoction is useful for diarrhea, cuts & wounds, fever, stomachache and vomiting. 
Root extract finds application in case of cold and cough.  
Chemical constituents 
Furocoumarins such as bergapten, heraclenol, heraclenin, angelicin and xanthotoxol 
have been isolated from the roots of S. tenuifolium (8). Two dihydropyranocoumarins, 
isopteryxin and anomalin, were also obtained from the ether extract of the roots of S. 
tenuifolium. Alcohol extract yielded sucrose and mannitol (9). Air-dried umbels of S.
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tenuifolium was found to contain 0.56% isoimperatorin, 0.07% osthole, 0.036% 
imperatorin, and 0.4% oxypeucedanin where as its roots possessed 1.2% oxypeucedanin, 
0.07% isoimperatorin, 0.02% osthole, and 0.007% imperatorin (10). The root essential 
oil was shown to contain limonene, elemol, terpineol, geraniol and eudesmol (11). S. 
tenuifolium leaves oil contained twenty-two compounds of which 3,5-nonadiyne 
(65.4%) and E-eudesmol (7.2%) were the major constituents. Its roots oil had sixteen 
constituents with 3,5-nonadiyne (89.7%) as the major component (12), (13). 
Biological properties 
Fatty acids and their esters isolated from S. tenuifolium was patented for their role as 
ganglioside metabolism accelerators (14). 
Acorus calamus
Acorus calamus L. (Amchi term: Tsu dak; Nepali language and trade name: Bojho)
belongs to the family Araceae. It is distributed in Nepal, Bhutan, China, India, Sri 
Lanka, northern Asia, Europe and Central and Northern America at the altitude range of 
100 to 2300 meter 
Traditional use
Dried rhizome has been used to treat headache, cold & cough, throat pain and toothache. 
It is also considered appetite stimulant. Rhizome extract is used to treat measles. It is 
also said to possess pesticidal properties. 
Chemical constituents 
Compounds such as E-asarone (20.5-75.6%) and cis-methylisoeugenol (2.4-48.9%) 
dominated the essential oils of the root, rhizome and leaves of A. calamus var 
angustatus collected from different parts of Japan. Other minor constituents in these 
essential oils were methyleugenol,  eugenol, trans-methylisoeugenol, elemicine, 
sekishone, cis- and trans-isoelemicine, D-pinene, camphene, E-pinene, limonene, 
1,8-cineole, p-cymene, linalool, terpinen-4-ol, D-terpineol, D-ylangene, E-elemene, 
E-gurjunene, G-cadinene, calamenene, calcacolene, epishyobunone, isoshyobunone and 
shyobunone (15). Mangolian A. calamus rhizome essential oil was found to contain 30 
components with shyobunone (17.3%) and acorenone (14.4%) as principal constituents 
(16). The Indian rhizome essential oil had E-asarone (92.68%) as the main constituent 
(17). The rhizome essential oil of A. calamus obtained from the lower region of the 
Himalayas had 29 components among which E-asarone (83.2%) and D-asarone (9.7%) 
predominated. The essential oil of the leaves had 30 constituents with E-asarone 
(85.6%) and linalool (4.7%) as major components (18). The essential oil of A. calamus
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roots obtained from Konya (Beysehir), Turkey contained 43 components with 
preisocalamendiol (17.3%), isoshyobunone (13.0%), 1,4-(trans)-1,7(trans) -acorenone 
(10.5%), camphor (5.9%), 2,6-diepishyobunone (2.6%) and E-gurjunene (2.5%) as the 
major constituents (19). Furthermore, the rhizome and roots of A. calamus were shown 
to contain different sets of compounds in their essential oils  The major components of 
the rhizome essential oil were E-asarone (47.43%), calamenene (9.75%), isocalamendiol 
(5.41%), preisocalamendiol (3.53%) where as the root essential oil possessed calamene 
(20.00%), aristolene (15.71%), acoradiene (14.19%) and cis-isoelemicin (9.51%) as 
major components (20). In the rhizome collected in Quebec, Canada, the essential oil 
contained preisocalamenediol, acorenone, shyobunone, and cryptoacorone (21). 
Lithuanian Acorus rhizome essential oil was shown to possess oxygenated 
sesquiterpenes such as shyobunone isomers (14.8-27.8%) and acorenones (9.6-21.4%). 
(Z)-asarone was detected in the rhizomes, but was present in noticeably minor amount 
(4.3-9.6%) as compared to the leaf oil The leaves had (Z)-asarone (15.7-25.5%) and 
(Z)-methylisoeugenol (2.0-4.9%) (22). Aside from Acorus leaves main components, 
(Z)-asarone (15.7-25.5%) and (Z)-methylisoeugenol (2.0-4.9%), other components 
detected in the leaves were (E)-caryophyllene, D-humulene, germacrene, linalool, 
camphor and isoborneol (23). 
Among some other isolated sesquiterpenoids include acoragermacrone (24) 
acolamone, isoacolamone (25) calamenone, calamendiol, (26) and acorafuran (27). A 
cyclobutane derivative probably formed by 2 + 2 cycloaddition of asarone named 
acoradin together with 2,4,5-trimethoxybenzaldehyde, 2,5-dimethoxybenzoquinone and 
ȕ-sitosterol were isolated from the rhizomes of A. calamus (28). Flavonoids such as 
galangin (28) and luteolin 6,8-C-diglucosides (29) have also been reported from A. 
calamus. The structures of representative isolated compounds are presented below. 
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Biological properties 
A. calamus rhizome and leaf essential oils were tested against three bacteria, four yeasts 
and ten fungal species. Leaf oil was found to be more antimicrobial than the rhizome oil 
(22). Anticonvulsant, antiveratrinic, and antiarrhythmic properties of A. calamus
essential oil have been reported (30). A. calamus extract showed depressant action on 
normotensive dogs, inhibited the rate of contraction of frog and dog hearts, relaxed the 
tone of isolated intestine, uterus, and bronchi and antagonized acetylcholine and 
histamine-induced spasms (31). A sedative as well as hypnotic potentiating principle 
has been separated from the volatile oil distillate of A. calamus (32). A. calamus 
essential oil’s spasmolytic activity in isolated organs of certain experimental animals 
has been studied. Its spasmolytic activity was found to be roughly 10% of that of 
papaverine (33). A. calamus aqueous and alcoholic extracts exhibited hypothermic and 
hypotensive activities (34). The ethanol extract of A. calamus had significant 
hypolipidemic activity (35). The ethanol extract of A. calamus inhibited growth of 
several cell lines of mouse and human origin. It was also found to inhibit production of 
nitric oxide (NO), interleukin-2 (IL-2) and tumor necrosis factor-alpha (TNF-alpha). 
These findings were indicative of antiproliferative and immunosuppressive potentials of 
the ethanol extract of A. calamus rhizome in vitro (36). The effects of water-soluble 
dried powder of alcoholic extract of the roots and rhizomes of A. calamus on strychnine 
induced convulsion activity in frogs, spontaneous motor activity and amphetamine 
induced hyperactivity in mice, pentobarbitone induced sleeping-time in rats and local 
anesthetic activity in guinea pigs and rabbits were studied. The extract neither offered 
protection to strychnine induced convulsions nor to acetylcholine induced contractions 
of rectum muscle. However, it inhibited caffeine citrate induced contractions in frogs. 
The extract further was found to antagonize spontaneous motor activity as well as 
amphetamine induced hyperactivity in mice. The extract, however, lacked local 
anesthetic activity (37). cis-Asarone was found to be antifungal agent of the oil of A. 
calamus against Helminthosporium oryzae (38). Antifungal proteins, haem peroxidases, 
were purified from the leaves of A. calamus. These enzymes inhibited hyphal growth of 
the phytopathogens such as Macrophomina phaseolina, Fusarium moniliforme and 
Trichosporium vesiculosum (39). The ethanol extract of A. calamus rhizome and a 
compound isolated from it, (Z)-asarone, exhibited strong insecticidal property (40). The 
mechanism of the tranquilizing action of asarone from A. calamus was studied. The 
sedative effect of asarone was found to depend on the depression of the ergotropic 
division of the hypothalamus (41). In acute and chronic experiments on mice, rats, cats 
and rabbits, D-asarone demonstrated diverse biological activities such as tranquilizing, 
sedative, antiulcer, spasmolytic and antisclerosing (42). However,D-asarone was found 
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to be mutagenic to Salmonella typhimurium TA100 in a concentration dependent 
manner. Its mutagenicity was comparable to that of induced by aflatoxin (43). A novel 
lectin showing potent mitogenic activity towards mouse splenocytes and human 
lymphocytes as well as inhibitory potential towards murine cancer cell lines has been 
purified from A. calamus rhizome (44). A. calamus extract decreased the cholesterol 
biosynthesis in the liver and had potential beneficial effect in atherosclerosis associated 
with hyperlipidemia (45).
Morchella esculenta
Morchella esculenta (L.) Pers. ex Fr. (Nepali language: Guchi chyau; Trade name: 
Chau) belongs to the family Helvellaceae. It is distributed around the world (Europe, 
Asia and North America) especially in the temperate regions. 
Traditional use  
It is a delicious food item with alleged aphrodisiac properties. 
Chemical constituents 
M. esculenta lipids had the following properties: acid no. 3.18, saponification no. 224.4 
and iodine no. 107.2. The fatty acids obtained after saponification included linoleic 
52.8%, oleic 23.6%, palmitic 14.1%, stearic 5.4% and heptadecanoic 0.4% acids (46). A 
peptide, J-L-glutamyl-cis-3-amino-L-proline, has been isolated from the cultured 
mycelium of M. esculenta (47). A comparative study of the chemical compounds of M.
esculenta collected from Japan, Germany and France was done. In all these three 
samples, the amount of moisture, proteins and lipids were almost same but the Japanese 
sample contained lower amount of ash than the Germany and France samples. The main 
fatty acids in all three samples were C16:0 (13%), C18:1 (apprx. 10%) and C18:2 
(apprx. 60%). Among the sterols, ergosterol was approximately 35% in the Germany 
and France samples where as the Japanese sample had about 15%. Ergosta-5,7-dienol 
(apprx. 36%.) was found in the Germany and France samples. 5'-GMP in the German 
sample was 5-fold more than in the Japanese sample (48). An amino acid called 
morchelline has been obtained from a culture broth of M. esculenta (49). Another amino 
acid, cis-3-amino-L-proline, was isolated from the growth medium containing mycelia 
of M. esculenta (50). Enzymes belonging to the class J-glutamyltranspeptidases with the 
ability to perform hydrolysis and transpeptidation of various J-glutamyl substrates have 
partially been purified from the cell-free extract of cultured mycelia of M. esculenta
(51). Furthermore, fraction containing lipoxygenase activity has partially been purified 
from an enzymatic extract from M. esculenta (52). Polysaccharides named as MEP-SP2 
and MEP-SP3 have been obtained from M. esculenta. MEP-SP2 with molecular weight 
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of 23,000 contained four kinds of monosacccharides. These monosacccharides were 
mannose, glucose, arabinose, and galactose in the mole ratio 1.75:4.13:0.71:0.68. 
MEP-SP3 has molecular weight of 44,000 and it consisted of six kinds of 
monosaccharides. They are xylose, glucose, mannose, fructose, arabinose, and galactose 
in the mole ratio 3.58:14.9:3.85: 1.77:51.3:0.53 (53). From a polar extract of M.
esculenta, a high molecular weight galactomannan polysaccharide was isolated. It 
consisted of about 2.0% of the dry fungal material weight and includes mannose 
(62.9%) and galactose (20.0%) (54). A steroidal derivative, ergosterol peroxide, has 
been detected in M. esculenta (55). 
Biological properties 
M. esculenta extract was found to be active against Escherichia coli, Bacillus 
mesentericus and Bacillus subtilis (56). Polysaccharide from M. esculenta had strong 
antibacterial and anti-actinomycete powers (57). The methanol extract (58) as well as 
ethanol extract (59) of M. esculenta demonstrated high antioxidant properties. The 
galactomannan polysaccharide isolated from M. esculenta demonstrated 
immunostimulatory activity (54). The platelet aggregation inhibitor isolated from the 
fruiting body of M.esculenta has been patented (60). A patent has been issued to 
skin-lightening cosmetics containing melanin formation inhibitor extracted from 
cultured M. esculenta (61).  
Swertia chirayita  
Swertia chirayita (Roxb. ex Fleming) Karsten (Nepali language and trade name: 
Chiraito) belong to the family Gentiaceae. It is found in the Himalayan region (Kashmir 
to Bhutan) and Assam at the elevation range of 1500 to 2500 meter. 
Traditional use  
It is used as tonic, febrifuge, stomachic, laxative, anthelmintic, antimalarial, 
antidiarrhoetic and finds applications in liver disorders as well.   
Chemical constituents 
Xanthones, seco-iridoid glycosides, triterpenoids and steroids constitute the major 
constituents of S. chirayita. Xanthones such as 1,3,5,8-tetrahydroxyxanthone, 
1,3,7,8-tetrahydroxy- xanthone, 1,3,8-trihydroxy-5-methoxyxanthone,1,3- dihydroxy- 
3,5-dimethoxyxanthone (swerchirin), 1,5,8-trihydroxy-3-methoxyxanthone, 1,8-di-  
hydroxy-3,7-dimethoxyxanthone, 1-hydroxy-3,5,8-trimethoxyxanthone, 1-hydroxy- 
3,7,8-trimethoxyxanthone, 1,5 dihydroxy-3,8-dimethoxyxanthone (chiratol), decussatin, 
mangiferin, mangostin, swertianin, norbellidifolin, bellidifolin, norswertianolin and  
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swertianolin have been obtained from S. chirayita. Among the isolated seco-iridoid 
glycosides include amarogentin, amaroswerin, sweroside-2c-O-3s,5s-
trihydroxy biphenyl-2scarboxylic acid ester, swerta-7,9(11)-dien-3-E-ol, sweroside, 
gentiopicroside, deacetylcentapicrin and amarogentin. Triterpenoids such as lupeol, 
oleanolic acid, ursolic acid, ȕ-amyrin, taraxerol, swertanone, swertenol, episwertenol, 
chiratenol, gammacer-16-en-E-ol and alkaloids such as gentianine, gentiocrucine, 
enicoflavine have also been isolated. Other isolated compounds include steroids such as 
E-sitosterol and E-sitosterol3E-D-glucoside; aromatic acids such as 
m-hydroxybenzoic acid, vanillic acid, 2,5-dihydroxyterephthalic acid and lignan such as  
syingaresinol (62) (63). S. chirayita essential oil contained hexadecanoic acid ethyl ester 
(19.54%), 4-(phenylmethyl)-pyridine (11.72%), ethyl oleate (7.82%), butylated 
hydroxytoluene (6.70%), linoleic acid ethyl ester (5.80%), butanedioic acid di-ethyl 
ester (3.21%) and 3a,6a-dihydro-2(3H,4H)-cyclopenta[b]furanone (2.13%) (64). The 
structures of representative isolated compounds are written below. 
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Biological properties 
S. chirayita is a well respected medicinal herb of the Himalayan region. It finds 
applications in the traditional medicinal systems of the Indian subcontinent such as the 
Ayurveda, Unani and Siddha. Several biological activities have been attributed to S.
chirayita. They include anticholinergic, anti-inflammatory, hepatoprotective, hypnotic, 
hypoglycemic (antidiabetic) and laxative (62). S. chirayita forms a part of patented 
traditional Tibetan medicinal formulations such as for treating hyperlipidemia (65), a 
preparation with antidote effect (66) and for treating liver and bladder diseases (67). 
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Jurinea dolomiaea 
Jurinea dolomiaea Boiss. ( Amchi term: Sila poe; Nepali language and trade name: 
Dhupjadi) belongs to the family Compositae. It is distributed in Western Asia, Turkey, 
Iran and the Himalayan region at the elevation range of 3200-3800 meter. 
Traditional use  
Root juice is taken in case of diarrhea and stomachache. The plant is widely used as 
incense.
Chemical constituents and biological properties 
Chemical and biological studies are lacking in this plant. 
Nardostachys grandiflora
Nardostachys grandiflora DC. (Synonym: Nardostachys jatamansi DC.) (Amchi term: 
Drak poe; Nepali language and trade name: Jatamansi) belongs to the family 
Valerianaceae. It is available in the Himalayan region (Garhwal to Bhutan), Tibet and 
west China at the elevation range of 3200 to 5000 meter. 
Traditional use  
The rhizome decoction is diuretic. It finds 
application in cases of indigestion, leprosy, fever 
and constipation. Leaf juices are taken in headache, 
cold & cough and altitude sickness.   
Chemical constituents 
In the essential oil of the roots of  N. grandiflora,
five compounds, nardostachnol 
(9-aristolen-1D-ol),'9,10-aristolene,
'1,10-aristolene, E-maaliene and 
1,2,9,10-tetradehydroaristolene were identified (68). In the essential oil of the rhizome 
of N. jatamansi purchased in Kathmandu market, fifteen compounds were identified of 
which thirteen were sesquiterpenes and one each aromatic and coumarin derivatives. 
Two major constituents in this essential oil were E-gurjunene (29.1%) and jatamansone 
(9.7%) (69). N. jatamansi rhizome essential oil from the Indian Himalayas contained 
nine monoterpenes (1.7%), 25 sesquiterpenes (43.9%) and 7 non-terpenic components 
(24.4%). The major sesquiterpenes include nardol (10.1%), D-selinene (9.2%), 
E-caryophyllene (3.3%), cubebol (2.9%), D-gurjunene (2.5%), J-gurjunene (2.3%) and 
D-humulene (2.3%) (70). Sesquiterpenes such as jatamols A and B (71), nardin (72) 
terpenoid ester, nardostachysin (73), spirojatomol (74), seychellene and seychelane (75) 
Nardostachys grandiflora
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and norseychelanone, D - and E -patchoulenes and patchouli alcohol (76) were also 
obtained from its rhizome. Furthermore, neolignans and lignans have also been reported 
from N. jatamansi roots (77). The structures of jatamansone, jatamol A, jatamol B and 
nardin are presented below.
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Biological properties 
N. jatamansi rhizome essential oil is fungistatic (78), antimicrobial (79) and nematicidal
(80). N. jatamansi rhizome is shown to be hepatoprotective (81). It also possessed
protective effect in the rat cerebral ischemia (82). The ethanol extract of whole plant of 
Nardostachys jatamansi increased HDL-cholesterol/total cholesterol ratio and decreased
total cholesterol/phospholipids ratio (83). N. jatamansi helped improve learning and 
memory in rats (84). N. jatamansi was found to play cytoprotective role in doxorubicin 
induced cardiac damaged rats (85). The ethanol extract of N. jatamansi displayed 
cytotoxic activity (IC50  30Pg/mL) against lung and prostate cancer cell lines (86). N. 
jatamansi showed antiarrhythmic activity (87). Valeranone, a compound isolated from
N. jatamansi prolonged barbiturate anesthesia, inhibited electroshock convulsions and 
potentiated the hypothermic effects of reserpine in mice and rats. It also contained 
antiulcerogenic activity and a weak hypotensive effect (88). The ethanol extract of N.
jatamansi roots has been found to be helpful in attenuating 6-hydroxydopamine-induced
parkinsonism in rats (89). The ethanol extract of N. jatamansi produced significant 
antidepressant-like effect in Swiss young albino mice in both tail suspension and forced 
swim tests (90). Jatamansone, a sesquiterpene obtained from N. jatamansi, is shown to
have antiarrhythmic and anticonvulsant (91) as well as tranquillizing (92) activities. The
essential oil obtained from N. grandiflora inhibited mycelial growth of Alernaria
brassicicola (93). 
nardinjatamol B 
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O
OH3C OH
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Pistacia khinjuk 
Pistacia khinjuk Stocks (Nepali language and trade name: Kakadsinghi) belongs to the 
family Anacardiaceae. It is distributed in Iran, Turkey, Baluchistan, Afghanistan, the 
Himalayan region (Kashmir to Nepal) and Myanmar at the elevation range up to 2400 
meter. 
Traditional use  
It works as tonic and expectorant. It has been used in cough, phthisis, fever and asthma. 
It is fried in ghee and given to dysentery patients. 
Chemical constituents 
In the essential oil obtained from the gum of P. khinjuk, D-pinene (61.13%) was the 
principal constituent followed by myrcene (8.28%), E-pinene (2.51%) p-cymene 
(2.50%), 3-carene (1.36%), linalool (2.76%), and E-caryophyllene (1.95%). Other minor 
terpenes such as D-thujene, camphene, D-fenchene, sabinene, D-phallendrene,
E-phallendrene, limonene, cineol, fenchone, borneol, and D-terpineol were also detected 
(94). Its leaves essential oil contained only monoterpene alcohols and was devoid of 
sesquiterpenes (95). The fruit essential oil contained 34 components of which 
cis-ocimene (24%), D-pinene (17.9%), myrcene (14%) and trans-ocimene (8%) were 
the major constituents (96). Hydrocarbons (0.9%), wax esters (1.3%), triglycerides 
(62.3%), free fatty acids (4.9%), 1:3-diglycerides (15.6%), 1:2-diglycerides (7.7%), 
2-monoglycerides (4.0%) and 1-monoglycerides (3.3%) were found in P. khinjuk lipids 
(97). Flavonoid glycosides such as quercetin-3-glucoside, quercetin-3-rutinoside,
myricetin-3-glucoside, myricetin-3-galactoside and myricetin-3-rutinoside have been 
detected in P. khinjuk (98).  
Biological properties 
Studies as regards to the biological properties of this plant are lacking. 
Neopicrorhiza scrophulariiflora
Neopicrorhiza scrophulariiflora (Pennell) D.Y. Hong (Synonym: Picrorhiza 
scrophulariiflora Pennell) (Amchi term: Hong len; Nepali language and trade name:
Kutki) belongs to the family Scrophulariaceae. It is distributed in Nepal, Bhutan, China, 
North India and North Myanmar at the elevation range of 3500 to 4800 meter.  
Traditional use 
The root paste is administered in fever in case of fever, gastritis, intestinal pain, cold 
and cough, headache, eye irritations and bile disorders. 
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Chemical constituents  
Major isolated compounds from this plant fall in 
the categories of iridoids, cucurbitacin glycosides 
and phenyl ethanoid and propanoids. A 
cucurbitacin glycoside 2E-glucopyranosyloxy-3,
16, 20, 22-tetrahydroxy-9-methyl-19-norlanosta-5,
24-diene, together with three iridoid glycosides, 
amphicoside (picroside-II), catalpol, aucubin and a 
phenol glycoside, androsin were isolated from the 
roots of P. scrophulariiflora (99). The 
underground parts of P. scrophulariiflora afforded 
three phenylethanoid glycosides, scrosides A, B and C and an iridoid glycoside, 
picroside IV (100). Non-glycosidic iridoids such as piscrocins A, B and C (101) as well 
as piscrocins D, E, F and G (102) have also been obtained from this plant. Two iridoid 
glucosides with 3,4-dihydrocatalpol skeleton, piscrosides A and B were obtained from
Picrorhiza scrophulariiflora (103). Further isolated iridoid glucosides include 
picrorosides A, B and C (101). Phenylethanoid and phenolic glycosides such as 
2-(3,4-dihydroxyphenyl)-ethyl-O-E-D-glucopyranoside, plantainoside,  scroside A, 
scroside B, scroside D, piceoside, 6-2-feruloyl-E-D-glucopyranoside and  
2-(3-hydroxy-4-methoxyphenyl)-ethyl-O-E-D-glucopyranosyl(o3)-E-D-glucopyranos
ide have also been isolated from P. scrophulariiflora roots (104). From the stems of P. 
scrophulariiflora, three phenyl glycosides, scrophenoside A, B, and C and two 
phenylethyl glycosides, scroside D and scroside E were obtained (105). A phenyl 
glycoside, scrophenoside D and a phenylethyl glycoside, scroside F have also been 
obtained from P. scrophulariiflora (106). Among the isolated cucurbitacin glycosides 
include 2-O-E-D-glucopyranosyl-3,16,20,25-tetrahydroxy-9-methyl-19-norlanosta-5,23- 
diene-22-one, 2-O-E-D-glucopyranosyl-3,16,20-trihydroxy-25-acetoxy-9-methyl-19- 
norlanosta-5,23- diene- 22-one and 2-O-E-D-glucopyranosyl-4,4,9,14-
tetramethyl-19-norpregn-5-en-20-one (107). The underground parts of P. 
scrophulariiflora has furnished three caffeoyl glycosides, scrocaffesides A, B and C 
together with two caffeic acid derivatives, 4-O-E-D-glucopyranosyl caffeic acid and 
4-methoxycaffeic acid (108). The structures of piscrocin A, piscrocin D, picroroside I 
and scroside A are presented. 
Neopicrorhiza scrophulariiflora
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Biological properties  
P. scrophulariiflora rhizome extracts are described as having immunomodulatory and 
anti-inflammatory activities (109). Total glycosides present in P. scrophulariiflora
represented the active ingredient responsible for the antioxidant effect. These glycosides 
had the potentiality to protect mesangial cells against oxidative stress induced by high 
glucose (110). The methanol extract of P. scrophulariiflora possessed superior nerve 
growth factor-potentiating activity (111). Picrosides I and II isolated from its rhizome 
were found to be nerve growth factor-potentiating compounds (112).The iridoids 
isolated from N. scrophulariiflora had hepatoprotective activities (102). Picroside II 
protected hepatocytes against injury and prevented hepatocytes from apoptosis (113). 
Scroside D, 2-(3,4-dihydroxyphenyl)-ethyl-O-ȕ-D-glucopyranoside and plantainoside D 
were found to be potent antioxidant (104). The compound plantainoside D was 
determined to be a potential candidate agent for protecting cardiotoxicity in 
adriamycin-exposed patients (114). Two cucurbitacin aglycons, picracin and 
deacetylpicracin, obtained from N. scrophulariiflora brought about inhibition of 
mitogen-induced T-lymphocyte proliferation at an IC50 value of 1 PM (115). 
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Juglans regia 
Juglans regia L. (Amchi term: Tar ka; Nepali language: Okhar) belongs to the family 
Juglandaceae. It is found in China, South East Asia, the Himalayan region and South 
East Europe at the elevation range of 500 to 4000 meter. 
Traditional use  
Bark paste is useful in arthritis, skin diseases and toothache. Bark paste is also 
beneficial for the hair growth. Seed coat is used for healing wounds. 
Chemical constituents  
From the bark of J. ragia L. var orientalis, glucose, mesoinositol, quercetin, quercitrin, 
and l-sakuranetin were obtained (116). From its stem bark, juglone, betulinic acid, 
regiolone and E-sitosterol have been isolated (117). Its seeds have afforded ellagitannins, 
glansrins A–C, together with other hydrolysable tannins (118).The hydrolysable tannins 
of 70% acetone extract of the seeds were identified as gemin D, casuariin, pedunculagin, 
tellimagrandin I, rugosin F and heterophylliin D (119). The major fatty acids found in J. 
regia were identified as linoleic (18:2n-6), D-linolenic (18:3n-3), oleic (18:1n-9), 
palmitic (16:0) and stearic acid (18:0). J-Tocopherol was the main tocopherol homolog 
present followed byG- and D-tocopherols. Tocopherols, particularly theJ-tocopherol,
contributed mostly to antioxidant activities of J. regia (120). Cyclic diarylheptanoids 
juglanin A and juglanin B were also obtained from the percarp of J. regia (121). The 
structures of representative isolated compounds are presented below.   
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Biological properties  
The trunk bark extract of J. regia showed high antioxidant, radical scavenging and 
anti-microbial properities (122). Its leaves too had strong antioxidant activity (123). 
Aqueous, water-alcohol, and alcoholic extracts of the nuts of J. regia brought about the 
contraction of the small intestines of guinea pigs and rats. The contraction was inhibited 
by atropine and papaverine (124). J. regia is also shown to possess hepatoprotective 
activity (125). Juglone, one of the components of J. regia, is a naphthaquinone and 
naphthoquinones have significant pharmacological properties such as cytotoxic, 
antibacterial, antifungal, antiviral, insecticidal, anti-inflammatory and antipyretic (126). 
Rheum australe
Rheum australe D. Don (Synonym: Rheum emodi Wall. ex Meisn.) (Amchi term: Chu 
tsa; Nepali language and trade name: Padamchal) belong to the family Polygonaceae. It 
is found in the Himalayan region and south Tibet at the elevation range of 3200 to 4200 
meter. 
Traditional use  
Rheum australe
Juices from the shoot portion of the 
plant are taken for cold & cough 
chest pain, diarrhea, dysentery and 
swelling. Root paste is used in case 
of strain and fractures. Leaves and 
petiole are considered 
antihelminthic and appetizer. 
Chemical constituents 
Anthraquinones such as rhein, physcion, aloe-emodin and chrysophanol (127) 
6-methylrhein and 6-methyl-aloe-emodin (128) have been obtained from R. emodi
rhizomes. The rhizome has also afforded two oxanthrone esters, revandchinone-1, 
revandchinone-2, an anthraquinone ether revandchinone-3 and a oxanthrone ether, 
revandchinone-4 (129). A sulfated emodin glucoside, emodin-8-O-E-D-glucopyranosyl-
6-O-sulfate together with two auronols, carpusin and maesopsin, were isolated from the 
roots of R. emodi (130). Its roots afforded anthrone C-glucosides such as 10-hydroxy- 
cascaroside C and 10-hydroxycascaroside D as well as chrysaloin 
1-O-E-D-glucopyranoside and 8-O-E-D-(6'-O-acetyl)glucopyranosylchrysophanol. In 
addition, cascaroside C, cascaroside D and cassialoin were also isolated (131). Other 
isolated compounds include E-sitosterol, piceatannol , d-catechin, daucosterol , 
piceatannol-4'-O-E- glucopyranoside, piceatannol-4'-O-E-D-(6''-O-galloyl)- 
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glucopyranoside, emodin-8-O-E-D- glucopyranoside and chrysophanol-8-O-E-D- 
-glucopyranoside (132). R. emodi  rhizome has further afforded two more 
anthraquinone derivatives named as rheinal and   rhein-11-O-E-D-glucoside (133). 
The structures of representative isolated compounds are presented below. 
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Biological properties
The ethanol and benzene extracts of R. emodi inhibited Helicobacter pylori in both in 
vitro and in vivo experiments (134). Chrysophanol, physcion, rhein and emodin isolated 
from R. emodi are shown to possess antifungal properties (127). Revandchinone-1 and 
revandchinone-3 obtained from R. emodi demonstrated modest degree of antibacterial 
activity. Revandchinone-4 was found to be superior antibacterial substance as compared 
to revandchinone-1 and revandchinone-3. A moderate level of antifungal activity was 
shown by all three isolated compounds revandchinone-1, revandchinone-2 and 
revandchinone-3 (129). The auronols from the plant such as carpusin and maesopsin 
were potent antioxidant in the DPPH assay (130). Several biologically active 
preparations from Rheum such as antivirally active fractions (135), antiinflammatorily 
active fractions (136) and antioxidant fractions (137) have been patented. R. emodi
forms a part of Unani herbal composition for the treatment of viral hepatitis and 
jaundice (138). Two patents on manufacture and application of R. emodi extraction 
solution and extract powder for improving motor ability and preventing anoxia are 
available (139), (140).
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Pinus wallichiana 
Pinus wallichiana A. B. Jacks. (Amchi term: Thesing, Doma; Nepali language: Gobre 
salla, Trade name: Salla simta) belongs to the family Pinaceae. It is found in 
Afghanistan, the Himalayan region and South East Tibet at around 4300 meter. 
Traditional use 
The plant resin is used in case of stomachache and body pain. It finds application in 
snake bite as well. 
Chemical constituents 
P. wallichiana yielded rosin (84%) and turpentine oil (16%). Turpentine oil contained 
89% D-pinene and 4.4% E-pinene as major constituents and rosin contained abietic acid 
(70%) (141). Furthermore, isomers of undecane, dodecane and tridecane and some 
sesquiterpenes as minor components were detected in turpentile oil where as rosin 
contained isopimaric acid and lambertianic acid as well (142). Its bark contains 12.2% 
tannin (143). The structures ofrepresentative isolated compounds are presented below.     
CH3
CH3
CH3
H3C
H
COOH
H
CH3 CH2
Biological properties
It forms a part of patented skin preparation formulation with anti-wrinkling properties 
(144).
Paris polyphylla
Paris polyphylla Sm. (Nepali language and trade name: Satuwa) belongs to the family
Liliacea. It is distributed in Bhutan, India, Laos, Myanmar, Nepal, Sikkim, Thailand,
Vietnam and China at the elevation range of 100 to 3500 meter.
Traditional use 
The root decoction is anthelmintic and antiseptic.
The root paste is used to heal cuts and wounds. It is 
also used as the antidote for aconitum poisoning. 
Chemical constituents
P. polyphylla is a rich source of diverse steroid 
saponins. The plant has been identified as a new 
abietic acid
CH
CH3
3
CH3
CH3
ȕ-pineneD-pinene
Paris polyphylla
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source of diosgenin (145). A phytoecdysone called paristerone has been isolated from 
the tuber of P. polyphylla (146). P. polyphylla tubers contained saponins such as 
pariphyllin, diosgenin-3-O-D-L-rhamnopyranosyl(1o 4)-D-L-arabinofuranosyl-(1o
3)-E-D-glucopyranoside (147), diosgenin 3-O-D-L-rhamopyranosyl-(1 o
2)-[D-L-arabinofuranosyl-(1 o 4)]-E-D-glucopyranoside, diosgenin 
3O-DL-rhamnopyranosyl-(1o4)-D-L-rhamnopyranosyl-(1o4)-[D-L-rhamnopyranosy
l-(1o2)]-E-D-glucopyranoside pregna-5,16-dien-3E-ol-20-one 3-O-E-chacotrioside, 
dioscin (diosgenin 3-O-E-chacotrioside) (148) pariphyllin A and B (149) polyphyllin A, 
B, C, D, E, F, and G, H (150) (23S, 25S)-3E, 23, 
27-trihydoxyspirost-5-en-3-O-E-D-glucopyranosyl-(1o6)-E-D-glucopyranoside, Paris 
saponin I, Paris saponin II, (25R) diosgenin-3-O-E-D-glucopyranoside, (25R) 
diosgenin-3-O-D-L-arabinofuranosyl(1o4)-E-D-glucopyranoside, (25R) diosgenin- 
-3-O-D-L-rhamnopyranosyl(1o2)-E-D-glucopyranoside, (25R) diosgenin-3-O-D-L-
-glucopyranosyl(1o3)[D-L-rhamnopyranosyl(1o2)]-E-D-glucopyranoside , (25R) 
pennogenin-3-O-D-L-arabinofuranosyl(1o4)[D-L-rhamnopyranosyl(1o2)]-E-D-gluco
pyranoside (151). The structures of paristerone and polyphyllin A are presented below. 
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Biological properties 
P. polyphylla contains antioxidant activity (152). P. polyphylla var. chinensis and P.
polyphylla var. yunnanensis had strong analgesic action. P. polyphylla var. chinensis
was also found to be potent sedative (153). P. polyphylla aqueous extract showed a
moderate antimutagenic activity against picrolonic acid- and benzo[a]pyrene-induced
mutations (154). P. polyphylla extract is shown to contain spermicidal activity in rat and 
human sperm (155). The methanol extract of the rhizomes of P. polyphylla Sm. var. 
yunnanensis was found to potently inhibit ethanol-induced gastric lesions in rats. Based 
on bioassay directed fractionation, four spirostanol-type steroid saponins were isolated 
and the isolated saponins strongly inhibited gastric lesions induced by ethanol and 
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indomethacin (156). The anti-tumor saponins have been isolated from the rhizome of P. 
polyphylla var. yunnanensis (157). Polyphyllin D isolated from P. pollyphyla has a 
strong apoptosis inducer in drug-resistant HepG2 cells making it a potent anticancer 
agent (158). Polyphyllin D was also found to inhibit human breast cancer cells (159). P. 
polyphylla rhizomes have afforded four diosgenin type saponins which were found to be 
tyrosinase inhibitors as well as antileishmanial agents (160). Furthermore, 
immuno-stimulating diosgenyl saponins have also been isolated from P. polyphylla
(161).
Asparagus racemosus 
Asparagus racemosus Willd. (Nepali language and trade name: Satawari, Kurilo)
belongs to the family Liliaceae. It is found in the Himalayan region, India, Malaysia, 
Australia and Africa. at the elevation range of 600 to 2100 meter. 
Traditional use  
It is used as demulcent, diuretic, aphrodisiac, antispasmodic, antidiarrhoeal, 
galactogogue and in rheumatism. 
Chemical constituents 
Among the isolated compounds from A. racemosus, bioactive steroidal saponins 
dominate. From its roots, steroidal saponins such as shatavarin I (162), shatavarin IV 
(163), shatavarin V (164), shatavarins V,X (165) and immunoside (166) have been 
isolated. A. racemosus fruits further afforded three more steroidal saponins, racemosides 
A, B and C (167). However, the original structures of shatavarin I and shatavarin IV 
were found not to be correct and were revised (168). A polycyclic pyrrolizidine alkaloid, 
asparagamine A, was also obtained from its roots (169). Glycosides of quercetin, rutin, 
and hyperoside have been detected in the flowers and fruit of A. racemosus. Flowers 
contained free quercetin. Anthocyanins such as cyanidin-3-galactoside and 
cyanidin-3-glucorhamnoside were found in the ripe fruits (170). A 
9,10-dihydrophenanthrene derivative named racemosol (171) and an isoflavone, 
8-methoxy-5,6,4ƍ-trihydroxyisoflavone 7-O-ȕ-glucopyranoside (172) are two other 
compounds obtained from the roots of A. racemosus. Its leaves afforded a flavone 
glycoside which was identified as flavone glycoside, 5-hydroxy 
3,6,4'-trimethoxy-7-O-E-D-glucopyranosyl [1o4]-O-D-D-xylopyranoside (173). One 
another compound, racemofuran, was also found in its roots (174). One disaccharide, 
3-O-E-D-glucopyranosyl-D-mannopyranosealong with two monosaccharides, 
D-glucose and D-mannose have been obtained from the ethanol extract of A. racemosus 
roots(175). Diosgenin is said to be found in the leaves of A. racemosus (176). The 
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structures of shatavarin IV, racemosol and racemofuran are presented below. 
O
O
O
CH3
H
H
CH3
H H
H
H
H3C
CH3
O
O
O
O
OHO
HO
HO
OH
HO
CH3
HO
OH
HO
H
H
HO
H
shatavarin IV 
OHH3CO
OCH3
HO
CH3
racemosol 
O
H3C
OH
CH3
OCH3
HO
racemofuran 
Biological properties
Host of beneficial biological properties are attributed to A. racemosus. Methanol extract 
of A. racemosus roots possessed antibacterial property (177). The roots were found to 
be antioxidant. An antioxidant compound, racemofuran, was identified in the roots 
(171). Furthermore, A. racemosus displayed potent antioxidant properties in vitro on
mitochondrial membranes of rat liver (178). A. racemosus root is shown to be 
antihelmintic (179), anti-diarrhoeal (180) and antilithiatic (181). A. racemosus was 
effective in reducing gastric ulcer in indomethacin-treated gastric ulcerative rats. The 
effect was comparable with that of the standard drug ranitidine (182). Methanol extract 
of A. racemosus demonstrated significant antidepressant-like activity (183). Saponin
glycosides (184) as well as an alkaloid asparagamine A (185) obtained from A. 
racemosus displayed antioxitocin activity. The plant is found to act as a galactagogue 
(186) and has an oestrogenic effect on the pregnant female albino rats mammary gland 
and genital organs (187). The aqueous extract of A. racemosus prevented
hepatocarcinogenesis induced by treatment with diethylnitrosamine (188). 
Asparagamine A , an isolate from A. racemosus, exhibited antitumor activity against 
human gastric carcinoma (189). A.racemosus is shown to contain the immunomodulant 
and immunoadjuvant potentialities (190) (191). A. racemosus root extracts were found 
to have wide-ranging stimulatory effects on physiology of insulinotropic pathways 
displaying its prospect for diabetes treatment (192). Furthermore, it exhibited potent 
antioxidant potential in diabetic conditions (193). The plant is found to be 
anti-inflammatory (194), antiallergic (195) and useful in dyspepsia (196). Two review 
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articles on A. racemosus are worth reading (197) (198). 
Valeriana jatamansii
Valeriana jatamansii Jones (Synonym: Valeriana wallichii DC.) (Amchi term: Drak 
poe; Nepali language: Sugandhawal) belongs to the family Valerianaceae. It is 
distributed in Afghanistan, the Himalayan region (Kashmir to Bhutan), Assam, Tibet, 
Myanmar and Western Central China at the elevation range of 1500 to 3000 meter. 
Traditional use  
Rhizome paste finds application in headache, sore throat, indigestion and people 
suffering from shock. Shoot juice is applied in case of eye ailments. 
Chemical constituents  
V. jatamansii volatile oil is found to contain seventy two compounds. Among them, 
sixty one compounds were identified of which major components were isovaleric acid 
(52.95%), patchouli alcohol (18.20%), 3-methyl pentanoic acid (6.89%), 
1-ethyl-4,4-dimethyl-cyclohex-2-en-1-ol (3.27%) and neocembrene A (2.12%) (199). V. 
wallichii DC leaf essential oil from Northwestern Himalayas had 20 components of 
which 3-methylvaleric acid (26.5%) and maaliol (39.2%) were the principal constituents. 
Maaliol (64.3%) and E-gurjunene (7.2%) were the main constituents in its root essential 
oil (200). Valepotriates have been detected in the aerial parts of V. jatamansii (201). 
Iridoids such as 1-homoacevaltrate, 11-homohydroxyldihydrovaltrate, 
10-acetoxy-1-homovaltrate hydrin and 10-acetoxy-1-acevaltrate hydrin together with 
valtrate, isovaltrate, homo- valtrate, acevaltrate, dihomovaltrate, didrovaltrate, 
1-homodidrovaltrate, 9- acetylhydroxyldihydrovaltrate, 10-isovaleroxyvaltrate hydrin 
and 10-isovaleroxydiavaltrate hydrin have been obtained from its rhizome (202). 
Sesqiterpenes like valeriananoids A, B and C were also isolated from V. jatamansii 
rhizome (203). From the rhizomes and roots of V. jatamansii, flavone glycosides, 
acacetin7-O-ȕ-sophoroside and acacetin 7-O-(6
-O-D-l-rhamnopyranosyl)-ȕ-sophoroside have been isolated (204). The structures of its 
volatile oil components well as valtrate are given below.  
Biological properties 
V. wallichii DC essential oil contained potent antifungal efficacy (205). The essential oil 
was also found to be antibacterial (206). The aqueous extract of V. jatamansii together 
with pentobarbital sodium enhanced sedative and hypnotic effect and inhibited the 
spontaneous activity in mice as well as antagonized convulsive action induced by 
thiosemicarbazide (TSZ) (207). V. jatamansi forms part of several Chinese medicinal 
formulations which have been patented. These include formulations for treating cancer 
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(208), a medicated liquor for topically treating rheumatic arthralgia, pain and blood 
stasis due to traumatic injury, traumatic hemorrhage, sprain, pains in bones and muscles, 
rheumatic arthritis, and soft tissue contusion (209), a composition for externally treating 
rheumatalgia, arthralgia, myalgia, traumatic injury, rheumatism and rheumatoid arthritis 
(210) and a composition for treating acquired immunodeficiency syndrome (211). It is 
also a component of perfume preparations (212), (213). From V. wallichii,
6-methylapigenin was isolated which functioned as a competitive ligand for the brain 
GABA(A) receptors (214). 
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In conclusion, it can be said that the Dolpa medicinal plants show wide variety 
of the biological properties and complex array of the chemical structure diversity. 
Meticulous research and development works followed by bioprospecting endeavor are 
keys to exploit the valuable medicinal properties of these natural resources. 
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